155 related articles for article (PubMed ID: 8485924)
1. The effect of atrial natriuretic peptide infusion on renal haemodynamics and plasma lipoproteins in puromycin aminonucleoside nephrosis in rats.
Radin MJ; McCune SA
Clin Exp Pharmacol Physiol; 1993 Apr; 20(4):245-51. PubMed ID: 8485924
[TBL] [Abstract][Full Text] [Related]
2. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
Abassi Z; Weissman I; Karram T; Goltsman I; Hoffman A; Better OS; Winaver J
Am J Nephrol; 2013; 38(4):292-9. PubMed ID: 24080549
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
Valentin JP; Ying WZ; Sechi LA; Ling KT; Qiu C; Couser WG; Humphreys MH
J Am Soc Nephrol; 1996 Apr; 7(4):582-93. PubMed ID: 8724892
[TBL] [Abstract][Full Text] [Related]
4. Renal denervation potentiates the natriuretic and diuretic effects of atrial natriuretic peptide in anaesthetized rabbits.
Christy IJ; Denton KM; Anderson WP
Clin Exp Pharmacol Physiol; 1994 Jan; 21(1):41-8. PubMed ID: 8156651
[TBL] [Abstract][Full Text] [Related]
5. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome.
Valentin JP; Qiu C; Muldowney WP; Ying WZ; Gardner DG; Humphreys MH
J Clin Invest; 1992 Oct; 90(4):1302-12. PubMed ID: 1328296
[TBL] [Abstract][Full Text] [Related]
6. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats.
Palluk R; Veress AT; Sonnenberg H
Pharmacology; 1989; 38(4):214-25. PubMed ID: 2526952
[TBL] [Abstract][Full Text] [Related]
7. Increased glomerular atrial natriuretic peptide receptor affinity in experimental nephrotic syndrome.
Morgan TR; Morgan K; Vaziri ND; Pandian MR
Life Sci; 1992; 51(5):337-44. PubMed ID: 1320716
[TBL] [Abstract][Full Text] [Related]
8. Renal responses to atrial natriuretic peptide (ANP) in rats with non-oliguric acute renal failure induced by cisplatin.
Nagano N; Yagi M; Kato S; Furuya Y; Miyata S; Manabe N
J Vet Med Sci; 1995 Dec; 57(6):997-1002. PubMed ID: 8720036
[TBL] [Abstract][Full Text] [Related]
9. Atrial peptides and the renal response to hypervolemia in nephrotic rats.
Keeler R; Feuchuk D; Wilson N
Can J Physiol Pharmacol; 1987 Oct; 65(10):2071-5. PubMed ID: 2962709
[TBL] [Abstract][Full Text] [Related]
10. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study.
Diamond JR; Pesek I
Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the natriuretic response to atrial natriuretic peptide by alterations in peritubular Starling forces in the rat.
Mendez RE; Dunn BR; Troy JL; Brenner BM
Circ Res; 1986 Dec; 59(6):605-11. PubMed ID: 2949885
[TBL] [Abstract][Full Text] [Related]
12. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
Eiskjaer H; Pedersen EB
Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
[TBL] [Abstract][Full Text] [Related]
13. Renal interstitial pressure and tubuloglomerular feedback control in rats during infusion of atrial natriuretic peptide (ANP).
Morsing P; Stenberg A; Casellas D; Mimran A; Müller-Suur C; Thorup C; Holm L; Persson AE
Acta Physiol Scand; 1992 Nov; 146(3):393-8. PubMed ID: 1481694
[TBL] [Abstract][Full Text] [Related]
14. Renal vascular and excretory resistance to atrial natriuretic peptide in pre-cirrhotic, bile-duct ligated rats.
Valdivieso A; Boric MP; Riquelme A; Roblero J
Biol Res; 1993; 26(3):397-404. PubMed ID: 7606260
[TBL] [Abstract][Full Text] [Related]
15. Permissive role of dopamine in renal action of ANP in volume-expanded rats.
Katoh T; Sophasan S; Kurokawa K
Am J Physiol; 1989 Aug; 257(2 Pt 2):F300-9. PubMed ID: 2527470
[TBL] [Abstract][Full Text] [Related]
16. Renal response of anesthetized rats to low-dose infusion of atrial natriuretic peptide.
Soejima H; Grekin RJ; Briggs JP; Schnermann J
Am J Physiol; 1988 Sep; 255(3 Pt 2):R449-55. PubMed ID: 2970807
[TBL] [Abstract][Full Text] [Related]
17. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
[TBL] [Abstract][Full Text] [Related]
18. Renal interaction of atrial natriuretic peptide with angiotensin II: glomerular and tubular effects.
Rakugi H; Ogihara T; Nakamaru M; Saito H; Shima J; Sakaguchi K; Kumahara Y
Clin Exp Pharmacol Physiol; 1989 Feb; 16(2):97-107. PubMed ID: 2523767
[TBL] [Abstract][Full Text] [Related]
19. Concerted action of ANP and dopamine D1-receptor to regulate sodium homeostasis in nephrotic syndrome.
Fernandes-Cerqueira C; Sampaio-Maia B; Quelhas-Santos J; Moreira-Rodrigues M; Simões-Silva L; Blazquez-Medela AM; Martinez-Salgado C; Lopez-Novoa JM; Pestana M
Biomed Res Int; 2013; 2013():397391. PubMed ID: 23956981
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide in rats with experimental cirrhosis of the liver without ascites.
Olivera A; Gutkowska J; Rodriguez-Puyol D; Fernandez-Cruz A; López-Novoa JM
Endocrinology; 1988 Mar; 122(3):840-6. PubMed ID: 2963741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
